Latest Advisories

  • FDA Advisory No. 2015-006 || Warning Against Unnotified Adhesive containing Dibutyl Phthalate

    The Food and Drug Administration (FDA) Center for Cosmetic Regulation and Research (CCRR) received unnotified samples of Fashion Nail (artificial nail sets with nail adhesive) allegedly containing Dibutyl Phthalate (DBP). The product was tested by the Central Laboratory and was found to contain Dibutyl Phthalate. This substance is a banned ingredient included on the List of Substances which “Must Not Form Part of the Composition of Cosmetic Products” (Annex II Part I Ref. No. 675) of the ASEAN Cosmetic Directive (ACD).

    Read more...
  • FDA Advisory No. 2015-005 || Public Warning against Unscrupuous Individuals asking Solicitation in behalf of the Agency and its Offices

    A report has been received by this Office that a certain company received a call, through the mobile phone, from someone who introduced himself as an officer of the Food and Drug Administration.  The impostor is allegedly soliciting money to fund an FDA activity

    Read more...
  • FDA Advisory No. 2015-004 || Public Health Advisory on US-FDA’s Announcement of Recalled Apples Linked with the Outbreak of Listeriosis in the US

    FDA Advisory 2015-004 

  • FDA Advisory No. 2015-003-A || Babala sa Publiko sa Paggamit ng mga Hindi Rehistradong Gamot

     

     

  • FDA Advisory No. 2015-003 || Public Health Warning Against the Use of the following Unregistered Drug Products

     

Announcement

  • Scheduled Delay in Processing of Electronic Cosmetic Product Notification

    ANNOUNCEMENT

    TO : All Cosmetics Manufacturer, Traders, Distributors and other concerned parties
    DATE : 19 November 2014
    SUBJECT : Scheduled Delay in Processing of Electronic Cosmetic Product Notification
                                         (Cosmetic e-Notification)
  • QPIRA ID for Release

    ANNOUNCEMENT

    DATE        : 10 November 2014
    TO            : ALL REGISTERED QUALIFIED PERSON IN
    INDUSTRY REGULATORY AFFAIRS (QPIRA)
    FROM        :  ATTY. RONALD R. DE VEYRA, MBA, CESO VI
     Acting Deputy Director General - AFO
    SUBJECT   : QPIRA ID for Release
  • Temporary Suspension of Procurement for ITB 14-017

     BAC ADVISORY 2014-001

    for ITB 14-017

    Procurement and Delivery of One (1) Year Locked in Period and Shall be Deemed Renewed until Terminated for Consumable Supply with Fifty (50) Units Complimentary Free Use of Printers 4 in 1 Monochrome

    This is to inform all prospective bidders that the Procurement and Delivery of One (1) Year Locked in Period and Shall be Deemed Renewed until Terminated for Consumable Supply with Fifty (50) Units Complimentary Free Use of Printers 4 in 1 Monochrome (ITB 14-017) is still undergoing review of technical specification and clarifications of other requirements thus the aforementioned project is indefinitely suspended until further notice.

    Thank you.

    Read more...
  • Announcement

    For ITB 14-015

    Procurement of Supply, Delivery, Installation, Configuration Testing, Infrastructure (Hardware and Software) for One Hundred (100) VDI Users

    During the 2nd pre-bid conference, on 31 October 2014, 11AM at AFO Conference Room, FDA-Main Bldg., Alabang, Muntinlupa City, the FDA BAC will discuss with you the size of the monitor needed by the FDA end users.

    Read more...
  • Public Hearing on the New Guideline on Medical Device Registration

    Public Hearing on the New Guideline on Medical Device Registration

    TO : Medical Device Industries
    When : 3 November 2014, 9:00 am - 12:00 pm
    Public Hearing on the New Guidelines on Medical Device Registration
    Where : 3/F, AVR, Annex Building Food and Drug Administration,
    Alabang, Muntinlupa City

    For efficiency, participants shall register online through This email address is being protected from spambots. You need JavaScript enabled to view it. with the following prescribed format below:

    Email Subject  Public Hearing on the New Guideline on Medical Device Registration
    Body of Email
    Name of Participant : Last Name, First Name, MI.
    Company Name  
    Contact No(s)  
    Email Address  

    A confirmation slip will be sent as a reply, please bring a copy of your confirmation slip on the day of Public Consultation

    For your information, guidance, and compliance

Videos

  • Win the War Against AMR

    The misuse of antibiotics is creating resistant "superbugs" that may leave you or your family without effective treatment the next time antibiotics are needed.

  • FDA Public Assistance Information and Receiving (PAIR) Video Tutorial

    A step by step guide to filing an application for a License to Operate or a Certificate of Product Registration.
    By: Nicole Melanie Molera

  • Dr. Kenneth Hartigan-Go on Responsible Pharmaceutical Manufacturing by Interphil

    Dr. Kenneth Hartigan-Go talks about importance of CGMP in manufacturing pharmaceutical products, bioequivalence, importance of adverse drug monitoring, and ethical marketing communications.

Share Us on

Submit to FacebookSubmit to Google BookmarksSubmit to Twitter